3 August 2026 12:00 AM

Personalized genetic medicines may address unique disease variants, but scientific, regulatory, ethical, and economic barriers remain substantial.

26 July 2026 12:00 AM

Individualized genetic medicines may address exceptionally rare disorders, but evidence, manufacturing, safety, access, and regulation remain difficult.

25 July 2026 12:00 AM

Bayesian trial methods can integrate prior evidence, support adaptive decisions, and sharpen uncertainty estimates during therapeutic development.

24 July 2026 12:00 AM

An examination of how artificial intelligence can support health policy analysis while introducing new requirements for transparency, oversight, and equity.

23 July 2026 12:00 AM

Practical, evidence-based strategies for building a sustainable eating routine without relying on rigid rules or constant willpower.

23 July 2026 12:00 AM

An evidence-based overview of how organoids improve disease modeling, drug testing, personalized research, and regenerative medicine.